NCT06940037

Brief Summary

To critically examine biological, clinical, and behavioral modulators of progressive resistance training-associated exercise response heterogeneity in physical function and whole-body metabolism in older adults.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
53mo left

Started Aug 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress15%
Aug 2025Aug 2030

First Submitted

Initial submission to the registry

January 16, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 23, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

August 11, 2025

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2029

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2030

Last Updated

September 16, 2025

Status Verified

August 1, 2025

Enrollment Period

4.1 years

First QC Date

January 16, 2025

Last Update Submit

September 15, 2025

Conditions

Keywords

agingmobilityexercisesenescenceDNA methylationskeletal muscle

Outcome Measures

Primary Outcomes (2)

  • Precisely define the variability in changes in physical function

    Measured by the Short Physical Performance Battery (SPPB), a 0-12 categorical scale of walking speed, standing balance, and repeated sit-to-stand time, with higher scores reflecting better physical function.

    baseline, 6 months

  • Precisely define the variability in changes in blood glucose concentrations in response to a meal tolerance test

    Blood glucose concentrations (millimoles/liter) will be measured in response to a physiologically relevant meal challenge. Lower values are indicative of better metabolic health.

    baseline, 6 months

Secondary Outcomes (7)

  • Precisely define the variability in changes in skeletal muscle size.

    baseline, 6 months

  • Precisely define the variability in changes in skeletal muscle strength.

    baseline, 6 months

  • Precisely define the variability in changes in six-minute walk distance.

    baseline, 6 months

  • Precisely define the variability in insulin secretion in response to a mixed meal tolerance test.

    baseline, 6 months

  • Precisely define the variability in changes in the percentage of glycated hemoglobin in the blood.

    baseline, 6 months

  • +2 more secondary outcomes

Study Arms (2)

Progressive Resistance Training

OTHER

participants will attend exercise session 3 times per week.

Other: Progressive Resistance Training

Health Education

OTHER

participants will attend health educations classed 1 time per week.

Other: Health Education

Interventions

3 times a week

Progressive Resistance Training

once a week

Health Education

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • aged greater than or equal to 65 years
  • sedentary (Community Healthy Activities Model Program for Seniors physical activity questionnaire to identify and exclude persons engaged in regular (125 min/week or more) moderate intensity physical activity
  • at risk for mobility disability score of less than or equal to 10 (but greater than 3) on the SPPB
  • willing to be randomized into HE or PRT
  • willing to be transported or transport themselves to the clinical sites for the intervention and assessments

You may not qualify if:

  • unwillingness to provide informed consent
  • participation in lifestyle or pharmacologic intervention trial or structured program of exercise training in the past 6 months
  • an SPPB score of less than or equal to 3
  • osteoarthritis or condition with joint pain limiting daily life activities
  • significant weight loss or gain (7.5% of body weight) in past six months
  • current anti-coagulant or anti-platelet therapy (Coumadin, Eliquis, Pradaxa, Xarelto, heparin, Lovenox, Plavix)
  • clinically significant abnormality in any of the screening laboratory values, including those identified as outside of the "normal limits', that are deemed to be of concern for participation in the study by the study physician
  • acute or terminal illness
  • Mini Mental State Exam (MMSE) \<23
  • myocardial infarction in the previous 6 months or other symptomatic coronary artery disease
  • New York Heart Association Class III or IV congestive heart failure
  • serious conduction disorder (e.g., 3rd degree heart block), uncontrolled arrhythmia, or new Q waves or ST-segment depressions (\>3 mm) on ECG
  • chronic obstructive pulmonary disease requiring oxygen therapy
  • upper or lower extremity fracture in the previous 6 months
  • uncontrolled hypertension (150/90 mm Hg)
  • +11 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University

Boston, Massachusetts, 02111, United States

RECRUITING

Mayo Clinic

Rochester, Minnesota, 55905, United States

RECRUITING

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Nathan LeBrasseur, Ph.D, MS

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Data analysis team
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Progressive Resistance Training vs. Health Education
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 16, 2025

First Posted

April 23, 2025

Study Start

August 11, 2025

Primary Completion (Estimated)

August 31, 2029

Study Completion (Estimated)

August 31, 2030

Last Updated

September 16, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations